A child receives a vaccine shot at a health station in Quzhou county, in China’s northern Hebei province. Shares in Chinese generic drug makers have plunged following the introduction of the pilot programme. Photo: EPA

‘Painful’ consolidation ahead for China’s generic drug makers, as Beijing gets behind procurement revamp

  • 52 per cent difference in price on average between winning bids under centralised bulk drugs procurement pilot and last year’s lowest prices for the same drugs
Topic |   Pharmaceuticals

TOP PICKS

A child receives a vaccine shot at a health station in Quzhou county, in China’s northern Hebei province. Shares in Chinese generic drug makers have plunged following the introduction of the pilot programme. Photo: EPA
READ FULL ARTICLE